MOS
ALNY icon

MGO One Seven’s Alnylam Pharmaceuticals ALNY Stock Holding History

MGO One Seven’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Buy
880
+100
+13% +$30.2K ﹤0.01% 1321
2026
Q1 		$258K Sell
780
-53
-6% -$18K 0.01% 1218
2025
Q4 		$331K Buy
833
+133
+19% +$58.9K 0.01% 1073
2025
Q3 		$319K Buy
+700
New +$285K 0.01% 1003
2019
Q1 		– Sell
-31
Closed -$2K – 461
2018
Q4 		$2K Buy
+31
New +$2.38K ﹤0.01% 1538
2018
Q1 		$2K Buy
16
+3
+23% +$387 ﹤0.01% 1516
2017
Q4 		$2K Buy
+13
New +$1.63K ﹤0.01% 1490

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MGO One Seven's ALNY Position: Q2 2026 in Review

MGO One Seven increased its Alnylam Pharmaceuticals (ALNY) stake by 13% in Q2 2026, buying an estimated $30.2K and bringing the position to 880 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

MGO One Seven first reported a position in ALNY in Q4 2017 and has held it in 7 quarters since. The position peaked at $331K in Q4 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • MGO One Seven held 880 shares of Alnylam Pharmaceuticals worth $265K as of Q2 2026.
  • MGO One Seven bought 100 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $30.2K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of MGO One Seven's portfolio in Q2 2026, its #1321 holding.
  • MGO One Seven first reported a position in Alnylam Pharmaceuticals in Q4 2017 and has held it in 7 quarters since.
  • MGO One Seven's Alnylam Pharmaceuticals position peaked at $331K in Q4 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.